- Filed
- Aug 13, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 9, 2024 | 38.6M sh |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $14.69M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $14.52M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $37.74M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $38.46M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $197.61M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $129.73M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $230.98M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $164.94M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $74.02M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $91.57M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 19.66M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 19.62M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $1.04M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$55.46M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $163.73M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $183.79M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $211.67M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$1.25 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$2.79 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$1.25 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$2.79 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $7.13M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $14.53M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $19.78M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $44.41M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$26.84M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$58.87M |